664 related articles for article (PubMed ID: 28457228)
1. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome.
Labus JS; Hollister EB; Jacobs J; Kirbach K; Oezguen N; Gupta A; Acosta J; Luna RA; Aagaard K; Versalovic J; Savidge T; Hsiao E; Tillisch K; Mayer EA
Microbiome; 2017 May; 5(1):49. PubMed ID: 28457228
[TBL] [Abstract][Full Text] [Related]
2. Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients.
Liu T; Gu X; Li LX; Li M; Li B; Cui X; Zuo XL
BMC Microbiol; 2020 Jun; 20(1):168. PubMed ID: 32552668
[TBL] [Abstract][Full Text] [Related]
3. Microbial community and metabolomic comparison of irritable bowel syndrome faeces.
Ponnusamy K; Choi JN; Kim J; Lee SY; Lee CH
J Med Microbiol; 2011 Jun; 60(Pt 6):817-827. PubMed ID: 21330412
[TBL] [Abstract][Full Text] [Related]
4. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis.
Labus JS; Osadchiy V; Hsiao EY; Tap J; Derrien M; Gupta A; Tillisch K; Le Nevé B; Grinsvall C; Ljungberg M; Öhman L; Törnblom H; Simren M; Mayer EA
Microbiome; 2019 Mar; 7(1):45. PubMed ID: 30898151
[TBL] [Abstract][Full Text] [Related]
6. Alterations of Gut Microbiota in Patients With Irritable Bowel Syndrome Based on 16S rRNA-Targeted Sequencing: A Systematic Review.
Duan R; Zhu S; Wang B; Duan L
Clin Transl Gastroenterol; 2019 Feb; 10(2):e00012. PubMed ID: 30829919
[TBL] [Abstract][Full Text] [Related]
7. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.
Jacobs JP; Lagishetty V; Hauer MC; Labus JS; Dong TS; Toma R; Vuyisich M; Naliboff BD; Lackner JM; Gupta A; Tillisch K; Mayer EA
Microbiome; 2023 Jan; 11(1):5. PubMed ID: 36624530
[TBL] [Abstract][Full Text] [Related]
8. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
[TBL] [Abstract][Full Text] [Related]
9. Stool and urine trefoil factor 3 levels: associations with symptoms, intestinal permeability, and microbial diversity in irritable bowel syndrome.
Heitkemper MM; Cain KC; Shulman RJ; Burr RL; Ko C; Hollister EB; Callen N; Zia J; Han CJ; Jarrett ME
Benef Microbes; 2018 Apr; 9(3):345-355. PubMed ID: 29633639
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome and symptoms in females with irritable bowel syndrome: a cross-sectional analysis.
Kamp KJ; Plantinga AM; Cain KC; Burr RL; Tsai CS; Wu Q; So SY; Badu S; Savidge T; Shulman RJ; Heitkemper MM
Benef Microbes; 2024 May; 15(3):259-273. PubMed ID: 38821492
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of the bacterial microbiome in association with common intestinal parasites in irritable bowel syndrome.
Krogsgaard LR; Andersen LO'; Johannesen TB; Engsbro AL; Stensvold CR; Nielsen HV; Bytzer P
Clin Transl Gastroenterol; 2018 Jun; 9(6):161. PubMed ID: 29915224
[TBL] [Abstract][Full Text] [Related]
12. Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement.
Jacobs JP; Gupta A; Bhatt RR; Brawer J; Gao K; Tillisch K; Lagishetty V; Firth R; Gudleski GD; Ellingson BM; Labus JS; Naliboff BD; Lackner JM; Mayer EA
Microbiome; 2021 Nov; 9(1):236. PubMed ID: 34847963
[TBL] [Abstract][Full Text] [Related]
13. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.
Zeber-Lubecka N; Kulecka M; Ambrozkiewicz F; Paziewska A; Goryca K; Karczmarski J; Rubel T; Wojtowicz W; Mlynarz P; Marczak L; Tomecki R; Mikula M; Ostrowski J
Gut Microbes; 2016 Sep; 7(5):397-413. PubMed ID: 27662586
[TBL] [Abstract][Full Text] [Related]
14. Metatranscriptome analysis of blood in healthy individuals and irritable bowel syndrome patients.
Jagare L; Rozenberga M; Silamikelis I; Ansone L; Elbere I; Briviba M; Megnis K; Konrade I; Birka I; Straume Z; Klovins J
J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37335601
[No Abstract] [Full Text] [Related]
15. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers.
Krogius-Kurikka L; Lyra A; Malinen E; Aarnikunnas J; Tuimala J; Paulin L; Mäkivuokko H; Kajander K; Palva A
BMC Gastroenterol; 2009 Dec; 9():95. PubMed ID: 20015409
[TBL] [Abstract][Full Text] [Related]
16. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets.
Kim GH; Lee K; Shim JO
Microbiol Spectr; 2023 Feb; 11(1):e0212522. PubMed ID: 36652592
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of gut microbiotal compositional analysis of patients with irritable bowel syndrome through different bioinformatics pipelines].
Zhu SW; Liu ZJ; Li M; Zhu HQ; Duan LP
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):231-238. PubMed ID: 29643520
[TBL] [Abstract][Full Text] [Related]
18. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification.
Lyra A; Rinttilä T; Nikkilä J; Krogius-Kurikka L; Kajander K; Malinen E; Mättö J; Mäkelä L; Palva A
World J Gastroenterol; 2009 Dec; 15(47):5936-45. PubMed ID: 20014457
[TBL] [Abstract][Full Text] [Related]
19. Impact of auricular percutaneous electrical nerve field stimulation on gut microbiome in adolescents with irritable bowel syndrome: A pilot study.
Bora G; Atkinson SN; Pan A; Sood M; Salzman N; Karrento K
J Dig Dis; 2023 May; 24(5):348-358. PubMed ID: 37448237
[TBL] [Abstract][Full Text] [Related]
20. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
